OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

The Cambridge Crystallographic Data Centre

Trustees’ report and financial statements for the year ending 31st December 2025

Table of Contents

About the Cambridge Crystallographic Data Centre (CCDC) and its purpose ........................................ 4

We shape the future of structural science: ........................................................................................................................................ 4 What we do .................................................................................................................................................................................................................. 4 What makes us different? ............................................................................................................................................................................... 5 Supporting the community ........................................................................................................................................................................... 5 Our strategy: advancing structural chemistry worldwide .................................................................................................... 6 Our strategic aims, vision, and mission ................................................................................................................................................ 7 Our values...................................................................................................................................................................................................................... 7 Public benefits ........................................................................................................................................................................................................... 8 Delivering our vision ................................................................................................................................................................ 8 Scientific innovation ............................................................................................................................................................................................12 Impact of the CCDC in worldwide research .................................................................................................................................... 13 CCDC Studentships ............................................................................................................................................................................................. 14 Key product releases ............................................................................................................................................................. 15 New database format ......................................................................................................................................................................................... 15 Covalent docking ................................................................................................................................................................................................... 15 CSD-Frameworks .................................................................................................................................................................................................. 16 PXRD matching and optimisation ......................................................................................................................................................... 16 Force field optimisation and interaction networks .................................................................................................................. 16 Structure validation ............................................................................................................................................................................................. 16 Looking forward ..................................................................................................................................................................................................... 17 Financial review ........................................................................................................................................................................ 18 Principal funding ................................................................................................................................................................................................... 18 Expenditure .............................................................................................................................................................................................................. 20 Investment policy ..................................................................................................................................................................................................21 Reserves ........................................................................................................................................................................................................................23 Structure, management, and governance ................................................................................................................ 24 Governance ............................................................................................................................................................................................................... 24 Nomination Committee ..................................................................................................................................................................................25 Audit Committee ..................................................................................................................................................................................................25 Remuneration Committee ............................................................................................................................................................................25 Risk Committee ..................................................................................................................................................................................................... 26 Management and staffing ............................................................................................................................................................................ 26 Remuneration policy ......................................................................................................................................................................................... 27 Risk management ............................................................................................................................................................................................... 27 Going concern ........................................................................................................................................................................................................ 28 Looking into the future ....................................................................................................................................................... 29

Reference and administrative details of the Charity, its trustees and advisers ................................... 30

2

Statement of trustees’ responsibilities ……………………………………………………………………………………..……………………………………..32 Independent auditor’s report …………………………………………………………………………………………………………………………..……...33 Consolidated statement of financial activities ………………………………………………………………………………….………….….37 Consolidated balance sheet ………………………………………………………………………………………………………………………………….…39 Charity balance sheet ………………………………………………………………………………………………………………………………………………..40 Consolidated statement of cash flows ………………………………………………………………………………………………………………..42 Notes to the financial statements …………………………………………………………………………………………………………………………43

Trustees’ report and financial statements for year ending 31 December 2025

The Trustees present their annual report together with the audited financial statements of the group and the company for the year 1 January 2025 to 31 December 2025. The Annual Report serves the purpose of both a Trustees’ report and a Directors’ report under company law. The Trustees confirm that the Annual Report and financial statements of the company comply with the current statutory requirements: the requirements of the company’s governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

CSD Entry TABLAO – a potential platform for molecular solar thermal (MOST) energy conversion, storage, and release, added to the database in 2025.

3

About the Cambridge Crystallographic Data Centre (CCDC) and its purpose

We shape the future of structural science:

What we do

CCDC are world-leading experts in high-quality structural chemistry data and scientific software, which generate knowledge and insights for scientific research and development. Our outputs support the discovery and development of new pharmaceuticals, functional materials, and fundamental chemistry, in industry and academia.

We specialise in the collation, curation, preservation, dissemination and application of chemical structural data for use in biopharmaceutical discovery and manufacturing, materials development, and research and education.

We compile and distribute the Cambridge Structural Database (CSD), a certified, trusted database of fully curated and enhanced organic and metal-organic experimental crystal structures, used by researchers across the globe. Our cutting-edge scientific software empowers scientists and researchers to extract invaluable insights and knowledge from this vast dataset, driving new innovations and discoveries.

CSD Entry SADZEH – a hydrated form of elafibranor, added to the database in 2025. Elafibranor is a dual PPARα/δ-agonist drug used in the treatment of primary biliary cholangitis.

4

What makes us different?

High-quality, trusted data

Each chemical structure in the CSD undergoes extensive validation and cross-checking via automated workflows (utilising machine learning techniques and semantic rules) and through manual curation by our expert chemists, crystallographers, and data analysts. This means users can trust that the data in the CSD is accurate, consistent, and of the highest quality.

Furthermore, we enrich the data with bibliographic, chemical, and physical property information and a range of additional metadata. This adds further value and scope to the original structural data and enables scientists and machines to interpret the structures in a chemically meaningful way.

Managing this data so that it is both available and secure is a critical part of how the CCDC ensures the CSD remains an important global data repository. We continue to invest in multiple layers of cyber-security, work with third parties to test our systems and software for vulnerabilities and run ongoing cyber-security training with all staff.

Unique data

We enable researchers to publish small molecule experimental crystallographic data that otherwise would have remained unpublished and unknown, directly through the CSD. The CSD therefore contains data that isn’t available anywhere else in the world.

Intelligent software and expertise

Our in-house software experts keep up to date with the latest developments in global data and software standards, applying their knowledge and expertise to develop robust systems that provide researchers with the tools to access, search, visualise, analyse and meaningfully interpret the data in the CSD.

Knowledge

Using a novel application of existing and new algorithms and methods to explore the highquality structural data and physicochemical properties in the CSD, we can extract new scientific insights to advance structural science worldwide and assist in the making of new discoveries.

Supporting the community

We are committed to the advancement of chemistry and crystallography for the public benefit, serving the global chemistry community by helping to address our users’ challenges through high-quality data, scientific software, and specialist knowledge and expertise.

We offer a selection of products and services free of charge for the benefit of the scientific community. Our services cover a wide range of crystallographic tools, from data deposition, validation, advanced searching, and visualisation to teaching, research, and analysis.

5

Our strategy: advancing structural chemistry worldwide

The main objective of the not-for-profit charity is the general advancement and promotion of the science of chemistry and crystallography in all its branches for the public benefit.

The CCDC’s strategy is to deliver this through continued development of its people, data, science and partnerships, training, education and outreach.

Data

We aim to continue collecting, curating, making available, and learning from structural chemistry data on a deeper, faster, and more interlinked level. Additionally, we will continue to incorporate open and FAIR (Findable, Accessible, Interoperable, Reusable) data requirements.

Over the next five years, CCDC aims to expand its data by incorporating more meta data about solid forms into the CSD. This growth, along with enhanced interlinking of data, is supported by a new, continuously evolving, and scalable database architecture, ensuring a future-proof foundation for an increasingly interconnected structural science universe. Through updated editorial workflows and improved interactions with the wider scientific community and our depositors, we will capture and add more fields and metadata, as well as physicochemical data.

Science and partnerships

We endeavour to be a leader in structural scientific research by working with all our inhouse scientists, our research partners, commercial clients, and our international academic network. We will continue to develop strong partnerships and alliances, furthering our cause, as well as scaling up our global distribution network.

We will continue to invest in new approaches and infrastructure to continue our novel research and regular publishing in the scientific literature, to advance the field.

Training, education and outreach

Through our global training, education, and outreach initiatives, we are committed to advancing structural science and equipping the next generation of scientists. This effort supports the wider adoption of CCDC’s software and data in both academia and industry. A key part of this mission is our growing CSD Champions network: passionate volunteers who use the CSD in research and education. These champions help us engage with new and existing users in their regions, supporting the scientific community through education and outreach. In 2025, CCDC and our CSD Champions delivered over forty training events worldwide.

6

Our strategic aims, vision, and mission

CCDC’s vision was renewed in July 2025 to be the catalyst for solving real world scientific challenges by connecting structural chemistry data, people and scientific tools.

The vision is underpinned by four building blocks:

Image to show the four building blocks that underpin CCDC’s renewed vision.

Our values

We have nine core values underpinning everything we do to ensure we achieve our mission. The CCDC and its staff have embedded these values in the ways we work across all levels and functions of the organisation.

7

Public benefits

The CCDC Board of Trustees holds in high regard the principle of public benefit and requires the executive team, the wider senior leadership, and staff of the CCDC to pursue policies that demonstrate this. At its quarterly meetings, the Board of Trustees reviews ongoing charitable activities to ensure consistency with our charitable objectives. The Board of Trustees is aware of the Charity Commission’s guidance on public benefit and has had regard to it in determining the Charity’s aims and objectives and in the way it carries out its activities.

CCDC staff and trustees in May 2025.

Delivering our vision

In 2025, the Cambridge Structural Database (CSD) grew by 5% to almost 1.4 million structures. This growth resulted from contributions by over 15,000 researchers from 100 countries.

Four data releases were delivered through our desktop software and up to the minute data was provided through our online services, namely Access Structures and WebCSD. Curated data collections, known as CSD Subsets, were also updated alongside our desktop releases to facilitate targeted research. These subsets are often developed in collaboration with external experts and provide a great starting point for specific research projects.

8

Chart showing the growth of the Cambridge Structural Database (CSD).

The CSD Communications initiative, which enables direct sharing of crystal structure data without the need for an associated scientific article, accounted for over 6,000 new entries, representing more than 10% of the year's additions. The total number of structures shared through this method now exceeds 69k. The CCDC also supported researchers worldwide by helping to add entries into the CSD from historical hardcopy, printed information.

Efforts were made to enhance existing data within the CSD:

During the year we automated more of our data integrity checks and worked closely with publishers when data integrity issues were identified. By the end of 2025 a total of 1,218 structures had been retracted from the database (up from 1,002) due to data or publication integrity concerns and our users were kept informed through a dedicated FAQ.

In 2025 the CCDC marked the 60th anniversary of the CSD. The celebrations included a series of online panel webinars on frontiers in structural science featuring members of the community; a keynote lecture at the European Crystallographic Meeting (ECM35) titled “Breaking Boundaries, Creating Connections: The Cambridge Structural Database at 60” ; and an evening reception held during ECM35. The reception was jointly organised with FIZ Karlsruhe, the curators of the Inorganic Crystal Structure Database (ICSD), and featured contributions from community representatives including Professor Santiago

9

García-Granda, President of the International Union of Crystallography (IUCr), Professor Marijana Đaković, Past President of the European Crystallographic Association (ECA), and the CCDC’s Chair of Trustees, Professor Susan Bourne. The remaining articles of the Virtual Special Issue of Crystal Growth & Design "Legacy and Future Impact of the Cambridge Structural Database: A Tribute to Dr Olga Kennard" were also published.

The CCDC continued to support our global scientific community, and to further that support, we expanded the CSD Champions network. This volunteer programme helps to train users in more regions. We participated in and supported many international conferences both in-person and virtually, and the CCDC and our CSD Champions delivered over forty workshops at crystallographic schools and training events. These included events in the UK, Poland, Italy, France, Spain, Romania, Canada, USA, Jamaica, Algeria, South Africa, Colombia, Brazil, Argentina and India.

During 2025, the CCDC also ran six free virtual workshops over two series. These online training sessions hosted attendees from all over the world, and overall counted 785 attendees at the live sessions, a similar figure as 2024.

In total, through our in-person and online tutored sessions delivered by CCDC and our CSD Champions, we trained over 1,900 people at live events, with a small growth (1%) compared to 2024.

Map showing the location of people who attended CCDC Virtual Workshops in 2025, countries with at least one attendee shown in blue.

As well as supporting and hosting virtual global events, the CCDC established and enriched its educational resources. These resources include guided step-by-step workshops, how-to videos, and software tips shared on social media to help users explore the CSD and associated software. We also improved and expanded our collection of modules designed

10

for teaching chemistry in high school and undergraduate programmes, covering a range of topics from molecular confirmations to stereochemistry and hapticity.

To inspire the next generation of structural scientists, CCDC hosted an in-person event at the Cambridge Festival with our Crystal Adventures activity. Participants of all ages hunted for the structures of everyday compounds, viewed crystal growth in real time under the microscope, matched proteins to ligands with a card game, and built crystal structure models.

Through the CCDC Engagement Grant programme, we also supported individuals outside CCDC in creating resources or activities to increase school student and public engagement in crystallography and structural science. These included classroom activities, booklets and comics to introduce children to chemistry and crystallography, and an image competition resulting in a calendar. All resources created in 2025 will be shared through the CCDC website once available. Seven new projects were awarded an Engagement Grant at the end of 2025, ranging from educational videos to crystal growing activities. The outputs will be shared in 2026 / early 2027.

As well as supporting scientists to contribute to advancing structural science for the public benefit, the CCDC supported early-stage structural scientists at 20 events worldwide through the provision of early career prizes and sponsorships.

In 2025 CCDC also hosted three students over the European summer months for paid placements. The placements involved typing up legacy data, enrichments to the CSD, connecting morphologies to CSD structures, as well as the creation of educational resources. The 2025 cohort were undergraduate students in the UK. These projects helped the students familiarise themselves with a range of scientific software and learn about the importance of good data management practices before resuming their academic studies.

We also hosted four academics for extended periods; Professor Izabela Madura from the University of Warsaw, Poland; Professor Alice Brink from the University of Free State, South Africa; Dr Aleksandar Višnjevac from Ruđer Bošković Institute, Croatia; Professor Daniele Toti from the Catholic University of the Sacred Heart, Italy. This allowed us to establish new scientific collaborations, discuss joint articles, learn more about how our tools are being used in academia and provided our visitors with the opportunity to learn more about how to use the CSD for their research and teaching.

We continued to promote our Frank H. Allen International Research and Education (FAIRE) programme that provides free access to the CSD and associated software to scientists in eligible countries who may not otherwise have access. In 2025, 10 new institutions were awarded a campus-wide CSD licence under the FAIRE programme, taking the total number of active FAIRE licence holders to 66. Since its launch in 2017, the initiative has supported researchers in publishing over 160 scientific articles in primary research journals.

11

Map showing where our FAIRE programme was used in 2025. Lighter to darker shades represent a growing number of FAIRE holders ranging from one to nine.

Scientific innovation

CCDC has continued to innovate in 2025. Consistent with our mission, we worked across a broad range of chemistry areas: discovery science, pharmaceutical solid-state materials science, particle and surface chemistry, crystal structure prediction, and functional materials domains.

We share our science with our communities in several ways: through integration into our software, publications in the scientific literature, book chapters, webinars, and presenting talks and posters at international conferences.

Examples of key research areas where we have published this year include data-driven generation of conformational ensembles and ternary complexes for PROTAC (Proteolysis Targeting Chimeras) and other chimera systems; a survey of crystallographic quality metrics from crystallographic files (CIFs) in the CSD and combining experiment and prediction to explore surface chemistry and dissolution.

Other key research areas during 2025 were surface property modelling, particle informatics, interaction analysis, aromatics analyser, development of descriptors to support the catalysis community, MOF collection validation, hydrogen bond propensity validation, informatics meets energetics, voids analysis, blind docking, molecular flexibility statistics, AI tools in discovery science, blind docking, ligand preparation, fragment based peptide design, bioisosteric replacement and CSD molecular 3D shape descriptors.

12

Impact of the CCDC in worldwide research

The CCDC’s software and services continue to have impact in research across the world. So far, CCDC reference papers have been cited 2,442 times in publications listed on Web of Science in 2025.

Chart showing the worldwide distribution of citation counts (according to Web of Science) for papers citing at least one of the key CCDC reference papers published in 2025. FAIRE-eligible countries are highlighted with a red dot, showing that CCDC’s FAIRE programme to ensure access to data is impactful, allowing scientists in these countries to undertake interesting scientific studies.

While many publications fall into the Web of Science category of ‘Chemistry Multidisciplinary’ or ‘Crystallography’, 67 publication categories were featured in 2025 (119 have featured since the inception of the CCDC). A few unexpected but interesting categories featured this year. For example, one paper discussed co-former use in nutrition. Another paper this year is listed in the category of ‘Forestry’. In this case, the authors used

13

X-Ray crystallography and CCDC software in their analysis of Heartwood formation to understand an aspect of Tree Physiology.

----- Start of picture text -----
4% [4%2%]
5%
28%
8%
9%
14%
12%
14%
Chemistry Multidisciplinary Chemistry Physical
Crystallography Chemistry Inorganic Nuclear
Materials Science Multidisciplinary Biochemistry Molecular Biology
Chemistry Medicinal Chemistry Organic
Pharmacology Pharmacy Computer Science Interdisciplinary Applications
----- End of picture text -----

Chart showing the distribution of topics (according to Web of Science) for papers citing at least one of the key CCDC reference papers published in 2025. The top 10 categories are shown.

CCDC Studentships

CCDC is heavily engaged in the development of the next generation of researchers by supporting research (PhD) studentships through various combinations of direct financial support, software provision, and supervisory support. We are actively supporting five doctoral training centres in the United Kingdom and, in 2025, supported fourteen studentships in total. These include studentships in Italy and Brazil with the remainder based in the UK. All students and their academic supervisors were invited to participate in a dedicated Annual CCDC PhD Student Science Day meeting at the CCDC where they had the opportunity to network and present their research.

A photo of attendees at the CCDC PhD Student Science Day in June 2025.

14

Key product releases

2025 was an impactful year for product releases, with important new features made available to our users. The CCDC delivered 3 significant product launches over 2025, delivering a wide range of functionality in response to user needs. A major highlight was the launch of our new database format.

New database format

One of our most impactful projects of the past few years came to fruition in 2025 as we launched our new database format for the desktop. This project included a capability to store disorder information for more than 165,000 CSD entries, and enables users to work with this disorder natively in our tools, a feature that many users have requested.

A chart showing the rise of disordered structures in the CSD. Yellow shows structures with the improved modelling of how the disorder is represented. Blue shows structures with the historic way (supressed) disorder is represented in the CSD.

Covalent docking

In the Discovery space, we improved the Covalent Docking method in our docking software GOLD to make it faster and easier for our users. The software now automatically detects reactive groups, matches them with compatible residues, and applies the chosen reaction transformation. This advance aids the study of irreversible inhibitors.

15

CSD-Frameworks

The CCDC launched a new product suite in 2025 to better serve functional materials customers. CSD-Frameworks is a porous functional materials design software suite that is used to accelerate metal-organic framework (MOF) and other porous materials research, optimise materials design, and gain deeper insights into porous materials: all using trusted, curated data from the CSD.

PXRD matching and optimisation

The Powder X-ray Diffraction (PXRD) component of our visualisation and analysis software, Mercury, continues to be one of our most used features, and we added big enhancements in 2025, enabling users to import experimental powder patterns and optimise crystal structures against these patterns using the AutoFIDEL algorithm. This provides a powerful yet intuitive tool for PXRD analysis and structure solution.

Force field optimisation and interaction networks

Energetic methods to support the DigiCCAMMS grant program were a major focus in 2025. The grant project aims to extend the CSD-Particle suite to support the digitalisation of pharmaceutical manufacturing. Within this program two new components were launched:

Both underpin our work in CSD-Particle to provide capabilities to predict crystal morphology under experimental conditions.

Structure validation

In 2025, in collaboration with FIZ Karlsruhe, we expanded our free CellCheckCSD service to include inorganic structures alongside organic and metal-organic data from the CSD.

CellCheckCSD enables researchers to check, at a very early stage of crystal structure determination, whether a crystal structure is already present in the database, thus avoiding unnecessary and time-consuming redeterminations of known compounds.

In collaboration with the International Union of Crystallography (IUCr) CellCheckCSD was also incorporated into the IUCr journal workflows and their validation service, checkCIF, to aid structural integrity and duplicate checks at the point prior to publication.

16

Looking forward

We will continue to focus on delivering value for our users as we prioritise projects for 2026. A high priority for the centre is delivering and expanding search on the web through our Lattice platform, providing users with an accessible route to probe the CSD without the need for a desktop installation.

The DigiCCAMMS program will continue throughout 2026, delivering enhancements to our CSD-Particle suite with growth face functionality expected to be released in 2026 and a further major launch expected in 2027.

User experience is a vital part of our products and an area which will be a cornerstone of our work in 2026. This will include enhancements to CSD-CrossMiner, a program used to build pharmacophore queries and mine structural data to help in the development of new drug structures. The improvements are expected to make it easier and faster for users to customise pharmacophore queries and to save, reuse, and refine search results as ideas develop. During 2026 we will also be working to improve the user experience across our software suites for Mac users.

2026 will also see significant improvements in how industrial users can manage their proprietary crystal structure data though the delivery of a data management plug-in for our on-site platform. We will also continue to expand and develop the CSD and expect to release more disorder models in the CSD and extend links and connections between CSD entries.

Within the CSD-Materials suite users can anticipate more advanced void analysis tools, designed to increase the understanding of a particular structure and form part of a wider assessment of the risk of a more stable form being identified.

17

Financial review

Principal funding

The CCDC’s principal funds arise from the subscription fee to the CSD and its associated scientific software. Its subscribers are academic research institutions from around the globe and industrial companies, mainly within the pharmaceutical and biotech sectors, with some in other sectors such as agrochemistry, functional materials, big tech, and the chemical industry. The annual contributions required from the worldwide academic community are significantly discounted compared to the contributions requested from industrial subscribers, and special consideration is given to academic users with financial need in historically underrepresented nations. CCDC aims to set income from academic institutions at a level required to maintain the CSD. The income from non-academic users meets the costs of developing the database, enterprise architecture, and related software. Additionally, it enables the CCDC to invest in relevant scientific methods and applications’ research and development.

The CCDC received government grants for specific projects (restricted income) during 2025. It also received donations from its trading subsidiary, the CCDC Services Ltd, under a Deed of Covenant. Since 2023, the CCDC holds an investment portfolio from which it receives dividends that are reinvested.

In 2024, the charity introduced an online donations facility via its website in an effort to generate additional income; however, no funds have been received through this channel to end of 2025. The organisation does not currently have any volunteers to support fundraising activities of this nature and will keep the effectiveness of this facility under review. No complaints were received during the year. The CCDC is not presently registered with the Fundraising Regulator, for which the registration is voluntary.

----- Start of picture text -----
£550,328.00, 5%
£204,723.00, 2%
£753,414.00, 7%
Subscription fees
Trading income
Investment
Restricted income
£8,996,812.00,
86%
----- End of picture text -----

A chart showing the detailed breakdown of 2025 revenue from all sources.

18

----- Start of picture text -----
£10M
£9M
£8M
£7M
£6M
£5M
£4M
£3M
£2M
£1M
£0M
Subscription fees Trading income Investment Restricted income
2024 2025
----- End of picture text -----

A chart showing how the detailed breakdown of 2025 revenue from all sources compares to 2024.

----- Start of picture text -----
£11M
£10,505,277.00
£9,879,753.00
£10M
£9M
£8M
£7M
£6M
£5M
£4M
£3M
2024 2025
----- End of picture text -----

A chart showing total revenue in 2025 compared to 2024.

Revenue grew by 6% in 2025 compared to the previous year. This is largely due to increase in trading income(income generated from trading subsidiary) and restricted income.

19

Subscription fees remain at a similar level as 2024. Total revenue for the year was £10,505,277(2024: £9,879,753).

In 2025, we continued to promote the FAIRE programme that provides free access to the CSD to users who may not otherwise have access; heavy subsidies are also provided to users who have limited funds. The total monetary value of the subsidies amounted to £318,200 (2024: £609,659).

Expenditure

The activities undertaken in the year were carried out within the budget approved by the Board of Trustees. All the expenditures were spent for CCDC’s charitable purpose.

The total charitable expenditure in 2025 was £9,436,518, 13% reduction compared to 2024(£10,800,484).

----- Start of picture text -----
£13M
£376,551
£11M
£164,262
£1,962,420
£9M
£1,539,104
£7M
£5M
£8,461,513
£7,733,152
£3M
£1M
2024 2025
Direct Costs Support Costs Grant Costs
----- End of picture text -----

Staff costs

Staff costs continue to be the CCDC's largest expenditure. When the CEO stepped down in November 2024, staff recruitment was put on hold while we were recruiting for the new

20

head of the Centre. The new Executive Director was appointed in July 2025. The average total number of staff across the Group decreased from 109 to 96. Total staff costs for 2025 were £7,373,097 (2024: £8,196,052), reflecting a 10% decrease. Despite the lower headcount, CCDC continued to deliver the charitable activities set out in the plan by focusing on the key priorities.

Other operating costs

In response to challenging revenue growth, the Centre has implemented cost control measures to ensure financial stability. Consequently, recruitment costs have decreased compared to last year, from £44,731 in 2024 to £22,577 this year, as we have put recruitment on hold. For the few positions that have been filled, they were mainly recruited directly via our website. Other operational costs, including attending scientific meetings, consultants and legal expenses, have reduced. Cost saving measures are designed to ensure that our resources are managed effectively. Overall, the total operating costs excluding salaries have decreased by 21% compared to 2024, from £2,604,432 to £2,063,421.

In 2025, grants for sponsoring research students totalled £164,262, just below half of the spend in 2024 (£376,551). Lower commitments were made in 2025 as more was committed in previous year where costs were recognised up front. This is to ensure we have sufficient resources to deliver the training programs we are supporting. Three new students started in 2025 as planned. In total, CCDC co-sponsored 16 students this year (2024: 15) across nine UK universities, one Italian university and one Brazilian university.

The CCDC holds an investment portfolio that is managed by Newton Investment Management. It produced an unrealised gain of £900,598 (2024: gain £485,886). This brought the overall financial performance of the CCDC to a surplus of £1,960,505 in 2025 (2024: deficit £444,861).

Investment policy

Since 1987, CCDC has looked to build up its reserves to provide financial stability and to enable it to fund its research and development activities. The primary objective of the investment policy is to preserve the capital and income in the investment portfolio from inflation.

In 2015, the Board of Trustees reviewed the investment policy and as a result, Newton Investment Management Ltd were appointed as our investment managers. The monies were moved from the incumbent Investment Manager and invested into Newton Growth and Income Fund for Charities.

The investment policy sets no specific ethical constraints on the investment portfolio. However, it states that the portfolio should be invested in a socially responsible manner and the investment manager of the portfolio is expected to consider environmental, social, and governance (ESG) issues in their investment analysis and decision-making process, engaging with company management where appropriate.

It is the practice that the investment advisers attend regular meetings with the Board of Trustees and report on the progress of the fund, and the CCDC’s investment into it. Detailed written reports are produced on a quarterly basis that value the portfolio and record its respective performance statistics. An integral part of the regular meetings is a detailed discussion on the content of the report with particular reference to the performance aspect. The table below shows the fund’s performance in the last five years.

21

*The 50% FTSE All Share, 25% FTSE World ex UK, 20% FTSE Gov All Stocks, 5% 7 Day compounded SONIA (cash) is used as a comparator for this portfolio. The Fund does not aim to replicate either the composition or the performance of the performance benchmark.

The Executive Team at the CCDC review monthly reports from the investment managers. The Trustees review the performance of the investment portfolio on a half-yearly basis. A more formal independent review of the investment manager and investment policy is carried out at least every five years or more frequently if circumstances require. An independent review was carried out during 2020. The Board were satisfied with the performance of Newton Growth & Income Fund for Charities. It was decided by the Board at that time to continue investing with Newton.

The fund produced a positive return in 2025 but underperformed its performance benchmark.

The Board made the decision to reinvest dividends in November 2022. The switch of fund from Income class to Accumulation class was implemented in January 2023. During 2025 £173,975 were reinvested (2024: £158,531). The value of the portfolio was £8,598,864 at the end of the year, representing an overall gain of £1,074,573 (2024: gain £644,417).

A photo taken from inside the CCDC building in Cambridge.

22

Reserves

The CCDC’s Reserves Policy is to maintain sufficient levels of reserves to enable normal operating activities to continue over a period of six months (at least) should a shortfall in income occur; it should take account of potential risks and contingencies that may arise from time to time. The Reserves Policy requires the retention of income sufficient to encompass:

The reserves policy is reviewed annually to take into consideration perceived risks and opportunities.

At the end of 2025, CCDC’s free reserve was £8,391k (2024: £6,282k). This is equivalent to approximately 88% of 2026 budgeted costs.

Our present position is:

Unrestricted Reserves

Designated Funds

31 Dec 2025 £10,774k

£2,382k

Fixed Asset Fund £2,109k Research and Development Fund £173k Sponsorship and Outreach Fund £0k Pension Provision Fund £0k Sustainability Fund £100k

Free Reserves

£8,391k

23

Structure, management, and governance

CCDC was incorporated as a Company Limited by Guarantee on 18 August 1987. It has no share capital and is a registered charity. The guarantee of each member is £1. The governing documents are the Articles of Association of the company (as amended November 2025).

In addition to CCDC, the charity operates the following subsidiaries:

Governance

The Charity is governed by the Board of Trustees who delegate operational management to the Executive Director (ED), supported by an Executive Leadership Team (ELT) covering all functions of the organisation, underpinned by decision making boards focussing on specific areas of the Centre.

In accordance with governing documents, potential Trustees are appointed by the Board based on recommendations by the Nominations Committee and on their specific skills, location, and diversity. Potential Trustees are sent an induction pack covering their obligations under Charity and Company Law, Articles of Association, Memorandum of Association and Codes of Practice, company policies, and a non-disclosure agreement. Potential Trustees are invited to attend Board meetings as observers. After that, the Board of Trustees and the individual consider their suitability to act as a Trustee ahead of their formal acceptance to the post at the Annual General Meeting (AGM). Upon acceptance and appointment, Trustees receive an induction to the business, which covers key aspects of the organisation, its operations, and salient Health and Safety information.

The Board of Trustees usually meets at the CCDC Cambridge UK office twice a year in May and November, with two further virtual meetings in February and August. Working to a

24

standing agenda, the meetings with the ED and the ELT provide oversight on the performance and progress of the Charity in line with strategy. Progress reports from all functions are presented to the Board at these meetings from the corresponding executive team members. In addition, the Board also receives management account reports regularly from the ED and produced by CCDC’s finance team, which include the financial performance, the investment performance and cash balances. The opportunity for all staff to interact with Trustees is encouraged and was specifically scheduled as part of the onsite meetings. All staff members have the option to ask questions in quarterly Q&A sessions at All-Staff meetings, where some trustees are usually present as well.

In addition to Board meetings, the Board members engage regularly with the ED to address any matters arising from the meetings in a timely manner, to address any issues that need action, or to discuss trends and any matters of interest to the advancement of the charity. In special cases, extra joint calls were convened as needed.

During 2025, meetings of the Board Committees, Nomination, Audit, Risk, and Remuneration were held in accordance with their terms of reference.

Nomination Committee

The purpose of the Nominations Committee is primarily to ensure that:

Audit Committee

The purpose of the Audit Committee is to ensure that:

Remuneration Committee

The purpose of the Remuneration Committee is to ensure that:

Assurance is provided to the Board that the CCDC has an effective and competitive People and Pay Strategy in place that supports the delivery of the strategy, promoting an effective, productive, high-performing, and diverse workforce.

All issues are overseen relating to the remuneration of staff, with specific responsibility for making recommendations to the Board regarding the Remuneration Policy and the executive’s remuneration.

25

Risk Committee

The purpose of the Risk Committee is primarily to ensure that:

Management and staffing

The day-to-day management of the CCDC is delegated by the Board of Trustees to the Executive Director (ED). Operational management is delivered by the Executive Leadership Team (ELT) and other managers who, in 2025, were:

Suzanna Ward Executive Director (appointed July 2025) Head of Data and Community (until June 2025) Garry O’Connor Head of Science Jonathan Betts Head of Commercial (departed August 2025) James Ellis Head of Operations (departed July 2025) Bing-Bing Waterman Head of Finance Michelle Christie Head of Human Resources and Organisational Design Matthew Lightfoot Interim Head of Data and Community (from July 2025) Tracy Allgood Joint Interim Head of Commercial (from September 2025) Marie Clements Joint Interim Head of Commercial (from September 2025)

These individuals constitute the Charity’s key management personnel. They provide reports for the Board of Trustees in support of effective governance and attend Board of Trustees meetings to present operational reports, position papers, and strategic progress.

On 1 July 2025, the Trustees appointed Suzanna Ward as Executive Director (ED) of the CCDC, a role previously titled Chief Executive Officer (CEO). Following the departure of the former CEO in November 2024, and prior to the appointment of the new ED, the responsibilities of this role were carried out collectively by the ELT, under the guidance of the Trustees.

During 2025 the CCDC commenced recruitment for a Head of Commercial and a Head of Technology and Product following the departures of the Head of Commercial and Head of Operations. Interim arrangements were put in place to ensure continuity of leadership.

26

Remuneration policy

The Board of Trustees give their time freely and no trustee received remuneration during the year. Details of trustees’ expenses are disclosed in Note 12 to the accounts. The Board delegates the directing, controlling, and day-to-day operation of the Charity to the ED, who is supported by key management personnel.

The pay of senior staff is reviewed annually and adjusted in line with the CCDC’s pay policy, which applies to all employees and is approved by the Board of Trustees as part of the annual budget process. The Remuneration Committee oversees any recommended salary changes or amendments to the organisation’s pay policy and considers relevant market trends supported by up-to-date benchmarking data provided by management.

Risk management

The leadership team maintains a register of key risks to the organisation, which covers the following areas:

Risk Register entries detail the likelihood and impact of risks occurring, the steps the organisation takes to mitigate these and areas where further action is required.

The Trustees have oversight of risks facing the organisation through the Risk Committee, which reviews the Risk Register at least once a year. Membership of the committee is kept under review. Day-to-day management of the risk register resides with the Executive Director.

Key threat types and approaches taken for mitigating these are summarised in the table below:

below:
Threat Type Approach
Data Assets
Our core mission in structural
science is underpinned by the
CSD, a high-quality database
respected across our community.
Our data assets drive significant value for the
CCDC and we continually invest in technology and
quality management to ensure data is available,
secure and trusted as a reliable and up to date
source of knowledge for our users.
Our core data product has been certified as
trustworthy by a third party (CoreTrustSeal) to
validate our approach.
Business Performance
The work of CCDC is almost
entirely self-funded through
licensingof softwareproducts,
Revenues and costs are budgeted annually with
monthly assessments made against the forecast at
a departmental level. In 2026 we plan to achieve

27

database subscriptions and
associated services. In addition to
product development, our work
also covers scientific research,
sponsorship of PhD studentships
and training.
Productivity improvements help
us maximise the charitable
impact of our income.
high levels of customer retention and explore new
applications for our data.
We maintain bank accounts in multiple currencies
to avoid spot-price currency conversion rates into
pound sterling.
We keep our use of technologies and suppliers
under review in order to support productivity
improvements.
Our product and service investments are kept
under review, with a new team structure being
implemented to drive customer centricity and
more effective product delivery.
Technology
Generative AI approaches need
high quality data assets such as
the CSD to train on.
Technology improvements can be
used to abuse the open access
versions of our offer.
We respond to unlicenced use of the CSD in
derived models and systems and we keep the
licencing terms for such use under review.
We monitor the use of our free services and keep
control measures under review to balance easy
access to products and services with the need to
generate the revenue needed to ensure our
organisation remains financially viable.
We have used the UK Government’s highly
respected CyberEssentials standard and other
third party analyses to maintain appropriate levels
of cyber-security.

Going concern

The CCDC ended 2025 in a strong financial position. The organisation delivered a surplus of £1.96m, a significant improvement compared with both the budgeted deficit of £168k and the prior year’s deficit of £445k. Total revenue for the year was £10.5m, representing growth on the previous year and exceeding budget expectations.

The Centre continues to maintain strong assets and cash reserves, supported by solid investment fund performance during the year. Together, these factors provide assurance that the organisation has sufficient resources to meet its obligations and maintain operations for at least the next 12 months.

The Board has reviewed the Centre’s financial forecasts, cash flow projections and risk assessments. Having considered these, the Board has a reasonable expectation that the CCDC has adequate resources to continue in operational existence for the foreseeable future.

28

Looking into the future

The organisational changes made during 2025, together with the appointment of a new Executive Director, provide a clearer structure for the next phase of the CCDC’s work. The updated vision introduced during the year will guide priorities across data, software and community activity.

The external environment is expected to remain challenging, shaped by global economic conditions, changes in research funding and wider market pressures. These factors will continue to be monitored as part of the Centre’s planning and risk management processes.

In the coming period, the Centre expects to continue investing in the development and long-term sustainability of its core datasets and scientific tools, ensuring they remain aligned with the needs of researchers and educators. This includes work to support the effective use of the CSD in computational approaches such as artificial intelligence, while maintaining the integrity and sustainability of the underlying data. The Centre also plans to expand cloud and web-based functionality to improve accessibility and support users working across different environments and institutions.

Ongoing engagement with the structural science community will remain central to planning. This includes continued collaboration with key partners such as the CCDC’s Crystal Form Consortium, Research Partners and the CSD Champions, whose insights collectively help inform the development of the organisation’s resources and services.

Overall, the CCDC’s renewed vision, to act as a catalyst for solving real world scientific challenges by connecting structural chemistry data, people and scientific tools, will remain central to its direction. Guided by four focus areas of Data, Community, Scientific Tools and Sustainability, the organisation is well positioned to continue supporting the evolving needs of structural science community.

The image shows the CCDC CSD timeline in the Cambridge office.

29

Reference and administrative details of the Charity, its trustees and advisers

FOR THE YEAR ENDED 31 DECEMBER 2025

Trustees

Professor Alessia Bacchi Professor Jonathan M Goodman Dr Nigel Pitchford, Vice Chair Professor Susan Bourne, Chair Dr Ola Engkvist Dr Ye Li Professor Emerita Jennifer Martin Anita De Waard

Company Secretary

HS Secretarial Limited 50/60 Station Road Cambridge CB1 2JH Company registered number 02155347 Charity registered number 800579 Registered office 12 Union Road Cambridge CB2 1EZ

Executive Director

Suzanna Ward (Appointed 1 July 2025)

Independent Auditors

MHA Building 4 Foundation Park Roxborough Way Maidenhead SL6 3 UD

30

Bankers

Barclays Bank Plc Cambridge CB2 3AA

Lloyds Bank PO Box 1000 Andover BX1 1LT

Solicitors

HCR Hewitsons 50-60 Station Road Cambridge CB1 2JH

Investment Advisers

Newton Investment Management Limited 160 Queen Victoria Street London EC4V 4LA

31

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

STATEMENT OF TRUSTEES' RESPONSIBILITIES FOR THE YEAR ENDED 31 DECEMBER 2025

The Trustees (who are also the directors of the Charity for the purposes of company law) are responsible for preparing the Trustees' Report including the Strategic Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Group and the Charity and of their incoming resources and application of resources, including their income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Group and the Charity's transactions and disclose with reasonable accuracy at any time the financial position of the Group and the Charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Group and the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Approved by order of the members of the Board of Trustees and signed on its behalf by:

................................................

Prof S Bourne

Chair of the Board of Trustees Date: 28 May 2026

Page 32

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

Opinion

We have audited the financial statements of The Cambridge Crystallographic Data Centre (the 'parent charitable company') and its subsidiaries (the 'group') for the year ended 31 December 2025 which comprise the Consolidated Statement of Financial Activities, the Consolidated Balance Sheet, the Charity Balance Sheet, the Consolidated Statement of Cash Flows and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the Trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group's or the parent charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.

Page 33

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (CONTINUED)

Other information

The other information comprises the information included in the Annual Report other than the financial statements and our Auditor's Report thereon. The Trustees are responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinion on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees' Report including the Strategic Report.

We have nothing to report in respect of the following matters in relation to which Companies Act 2006 requires us to report to you if, in our opinion:

Page 34

(A Company Limited by Guarantee)

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (CONTINUED)

Responsibilities of trustees

As explained more fully in the Trustees' Responsibilities Statement, the Trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the Trustees are responsible for assessing the Group's and the parent charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the Group or the parent charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor's Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's Report.

Page 35

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (CONTINUED)

Use of our report

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an Auditor's Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and its members, as a body, for our audit work, for this report, or for the opinions we have formed.

Carina Ralfs MSci (Hons) PhD FCA (Senior Statutory Auditor)

for and on behalf of

MHA Maidenhead, United Kingdom

Date: 01 June 2026

MHA is the trading name of MHA Audit Services LLP, a limited liability partnership in England and Wales (registered number OC455542).

Page 36

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2025

Note
Income from:
Donations and legacies
4
Charitable activities
5
Other trading activities
7
Investments
8
Total income
Expenditure on:
Charitable activities
10
Total expenditure
Net income/(expenditure) before net
gains on investments
Net gains on investments
15
Net income/(expenditure) before
taxation
Taxation
13
Net income/(expenditure) after
taxation carried forward
Unrestricted
funds
2025
£
200
8,996,612
753,414
204,723
9,954,949
8,458,405
8,458,405
1,496,544
900,598
2,397,142
(8,852)
2,388,290
Restricted
funds
2025
£
-
550,328
-
-
550,328
978,113
978,113
(427,785)
-
(427,785)
-
(427,785)
Total
funds
2025
£
200
9,546,940
753,414
204,723
10,505,277
9,436,518
9,436,518
1,068,759
900,598
1,969,357
(8,852)
1,960,505
Total
funds
2024
£
55
9,087,546
613,434
178,718
9,879,753
10,800,484
10,800,484
(920,731)
485,886
(434,845)
(9,962)
(444,807)

Page 37

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

Note
Net income/(expenditure) after
taxation brought forward
Transfers between funds
20
Net movement in funds before other
recognised gains/(losses)
Other recognised gains/(losses):
Other losses
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Net movement in funds
Total funds carried forward
Unrestricted
funds
2025
£
2,388,290
(435,839)
1,952,451
-
1,952,451
8,821,130
1,952,451
10,773,581
Restricted
funds
2025
£
(427,785)
435,839
8,054
-
8,054
(8,054)
8,054
-
Total
funds
2025
£
1,960,505
-
1,960,505
-
1,960,505
8,813,076
1,960,505
10,773,581
Total
funds
2024
£
(444,807)
-
(444,807)
(54)
(444,861)
9,257,937
(444,861)
8,813,076

The Consolidated Statement of Financial Activities includes all gains and losses recognised in the year.

The notes on pages 43 to 75 form part of these financial statements.

Page 38

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee) REGISTERED NUMBER: 02155347

CONSOLIDATED BALANCE SHEET AS AT 31 DECEMBER 2025

Note
Fixed assets
Tangible assets
14
Investments
15
Current assets
Debtors
16
Cash at bank and in hand
Current liabilities
Creditors: amounts falling due within one
year
17
Net current assets / liabilites
Total assets less current liabilities
Creditors: amounts falling due after more
than one year
18
Total net assets
Charity funds
Restricted funds
20
Unrestricted funds
20
Total funds
3,454,426
2,911,072
6,365,498
(5,563,683)
2025
£
2,108,870
8,598,864
10,707,734
801,815
11,509,549
(735,968)
10,773,581
-
10,773,581
10,773,581
3,752,830
1,637,244
5,390,074
(5,626,143)
2024
£
2,200,117
7,524,291
9,724,408
(236,069)
9,488,339
(675,263)
8,813,076
(8,054)
8,821,130
8,813,076

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:

................................................

Prof S Bourne

Chair of the Board of Trustees Date: 28 May 2026

The notes on pages 43 to 75 form part of these financial statements.

Page 39

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (A Company Limited by Guarantee) REGISTERED NUMBER: 02155347

CHARITY BALANCE SHEET AS AT 31 DECEMBER 2025

Note
Fixed assets
Tangible assets
14
Investments
15
Current assets
Debtors
16
Cash at bank and in hand
Current liabilities
Creditors: amounts falling due within one
year
17
Net current assets / liabilites
Total assets less current liabilities
Creditors: amounts falling due after more
than one year
18
Total net assets
Charity funds
Restricted funds
20
Unrestricted funds
20
Total funds
3,948,485
2,248,759
6,197,244
(5,762,581)
2025
£
2,108,870
8,762,353
10,871,223
434,663
11,305,886
(735,968)
10,569,918
-
10,569,918
10,569,918
3,951,250
977,276
4,928,526
(5,552,386)
As restated
2024
£
2,200,117
7,687,780
9,887,897
(623,860)
9,264,037
(675,263)
8,588,774
(8,054)
8,596,828
8,588,774

Page 40

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee) REGISTERED NUMBER: 02155347

CHARITY BALANCE SHEET (CONTINUED) AS AT 31 DECEMBER 2025

The Charity's net movement in funds for the year was £1,981,144 (2024 - £(468,440)).

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:

................................................

Prof S Bourne

Chair of the Board of Trustees Date: 28 May 2026

The notes on pages 43 to 75 form part of these financial statements.

Page 41

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2025

Note
Cash flows from operating activities
Net cash used in operating activities
22
Cash flows from investing activities
Dividends, interests and rents from investments
Purchase of tangible fixed assets
Purchase of investments
Net cash provided by/(used in) investing activities
Change in cash and cash equivalents in the year
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
23
2025
£
1,266,261
204,723
(23,181)
(173,975)
7,567
1,273,828
1,637,244
2,911,072
2024
£
(989,662)
178,718
(21,299)
(161,624)
(4,205)
(993,867)
2,631,111
1,637,244

The notes on pages 43 to 75 form part of these financial statements

Page 42

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

1. General information

The company is a company limited by guarantee. The members of the company are the Trustees named on page 30. In the event of the company being wound up, the liability in respect of the guarantee is limited to £1 per member of the company.

2. Accounting policies

2.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

The Cambridge Crystallographic Data Centre meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

The Consolidated Statement of Financial Activities (SOFA) and Consolidated Balance Sheet consolidate the financial statements of the Charity and its subsidiary undertaking. The results of the subsidiary are consolidated on a line by line basis.

The Charity has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of Financial Activities in these financial statements.

2.2 Going concern

The Cambridge Crystallographic Data Centre meets its day to day working capital requirements through the cash it holds and generates. The Charity undertakes a regular process of reviewing forecasts and projections to ensure that it has adequate resources for its continued operations and can draw on its investment portfolio to support its planned activities if required.

Management continuously reviews the trends in the biopharmaceutical market and wider growth trends in the technology and science fields. CCDC's data and scientific software offerings remain in good demand, and can furthermore help address new trends such as artificial intelligence, and the investments that are going into those efforts.

The consolidated balance sheet shows a net current asset position of £801,815 at the year end (2024: net current liability of £236,069). This is due to higher cash balance at the year end of £2,911,072. Creditors falling due within one year of £5,563,683 are mostly subscriptions in advance of £4,947,725.

The Trustees have a reasonable expectation that the Charity has adequate resources to continue operational existence for at least 12 months from date of approval of the accounts. For this reason, the Charity continues to adopt the going concern basis in preparing its financial statements

Page 43

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

2. Accounting policies (continued)

2.3 Income

All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

Subscription income is recognised over the period to which it relates, with income being received in advance deferred.

Trading income, consisting of software and consultancy advice is recognised as supplied while maintenance and support services are recognised over the period to which they relate.

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the company; this is normally upon notification of the interest paid or payable by the bank. Dividends are recognised once the dividend had been declared and notification has been received of the dividend due.

Grants are included in the Consolidated Statement of Financial Activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance Sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.

2.4 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.

Support costs are those costs incurred directly in support of expenditure on the objects of the company and include project management carried out at Headquarters. Governance costs are those incurred in connection with administration of the Charity and compliance with constitutional and statutory requirements.

Charitable activities and governance costs are costs incurred on the Charity's operations, including support costs and costs relating to the governance of the company apportioned to charitable activities based on staff roles and time.

Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.

2.5 Termination payments

Termination payments are expensed when the Charity can no longer withdraw the offer of these payments.

Page 44

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

2. Accounting policies (continued)

2.6 Foreign currencies

Monetary assets and liabilities denominated in foreign currencies are translated into sterling at rates of exchange ruling at the reporting date using HMRC monthly rate.

Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction.

Exchange gains and losses are recognised in the Consolidated Statement of Financial Activities.

2.7 Taxation

The Charity is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the Charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.

2.8 Tangible fixed assets and depreciation

Tangible fixed assets costing £10,000 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.

A review for impairment of a fixed asset is carried out if events or changes in circumstances indicate that the carrying value of any fixed asset may not be recoverable. Shortfalls between the carrying value of fixed assets and their recoverable amounts are recognised as impairments. Impairment losses are recognised in the Statement of Financial Activities.

The cost of replacing and upgrading scientific computer equipment is written off as maintenance to scientific equipment in the income and expenditure account.

Assets in the course of construction are included at costs incurred to date. Depreciation on these assets is not charged until they are brought into use.

Tangible fixed assets are carried at cost, net of depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful live

Depreciation is provided on the following bases:

Page 45

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

2. Accounting policies (continued)

2.9 Investments

Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance Sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Consolidated Statement of Financial Activities.

Investments in subsidiaries are valued at cost less provision for impairment.

2.10 Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

2.11 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

2.12 Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Consolidated Statement of Financial Activities as a finance cost.

2.13 Financial instruments

The Group only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

Page 46

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

2. Accounting policies (continued)

2.14 Pensions

The Charity participates in the Universities Superannuation Scheme, a defined benefit and defined contribution hybrid scheme which is externally funded and contracted out of the State Earningsrelated Pension Scheme. The fund is valued every three years by a professionally qualified independent actuary using the projected unit method, the rates of contribution payable being determined by the trustees on the advice of the actuary. In the intervening years, the actuary reviews the progress of the scheme. Pension costs are accounted for over the period during which the Charity benefits from the employees services.

The Charity also participates in the Cambridge University Assistants' Contributory Pension Scheme (CUACPS) which is a defined benefit and defined contribution hybrid scheme. The Charity's contributions are affected by a surplus or deficiency in the CUACPS.

For both schemes, the Charity is unable to identify its share of the underlying assets and liabilities in the Scheme on a consistent and reasonable basis. The Charity therefore accounts for its contributions to the schemes as if it were a defined contribution scheme.

The Charity operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Charity pays fixed contributions into a separate entity. Once the contributions have been paid the Charity has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Charity in independently administered funds.

2.15 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Group and which have not been designated for other purposes.

Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Group for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Investment income, gains and losses are allocated to the appropriate fund.

Page 47

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

3. Critical accounting estimates and areas of judgement

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Critical accounting estimates and assumptions:

The Charity makes estimates and assumptions concerning the future. The resulting accounting estimates and assumptions will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below.

Critical areas of judgment:

FRS 102 makes the distinction between a group pension plan and a multi-employer pension scheme. A group plan consists of a collection of entities under common control typically with a sponsoring employer. A multi-employer scheme is a scheme for entities not under common control and represents (typically) an industry-wide scheme such as that provided by USS. The accounting for a multi-employer scheme where the employer has entered into an agreement with the scheme that determines how the employer will fund a deficit results in the recognition of a liability for the contributions payable that arise from the agreement (to the extent that they relate to the deficit) and the resulting expense is recognised in the Consolidated Statement of Financial Activities. The Executive Committee are satisfied that the scheme provided by USS meets the definition of a multi-employer scheme and has therefore recognised the discounted fair value of the contractual contributions under the funding plan in existence at the date of approving the financial statements.

4. Income from donations and legacies

Unrestricted
funds
2025
£
Donations
200
Total 2024
55
Total
funds
2025
£
200
55
Total
funds
2024
£
55

Page 48

(A Company Limited by Guarantee)

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

5. Income from charitable activities

Unrestricted
funds
2025
£
Scientific Activity - Subscription Fees
8,723,604
Grant income
113,734
Royalty income
159,274
8,996,612
Total 2024
8,966,989
Restricted
funds
2025
£
-
550,328
-
550,328
120,557
Total
funds
2025
£
8,723,604
664,062
159,274
9,546,940
9,087,546
Total
funds
2024
£
8,656,734
266,636
164,176
9,087,546

During the year, the unrestricted funds totalled £8,996,612 (2024: £8,966,989) which was made up of £8,723,604 (2024: £8,656,734) of subscription fees, £113,734 (2024: £146,079) of grant income and royalty income of £159,274 (2024: £164,176). The restricted funds totalled £550,328 (2024: £120,557) which was made up of grant income.

6. Turnover

The whole of the turnover is attributable to the principal activities of the Charity.

A geographical split of turnover is disclosed as follows: United Kingdom 23% (2024 - 23%) , Other EU 24% (2024 - 25%) and Rest of the World 53% (2024 - 52%).

Page 49

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

7. Income from other trading activities

Income from non charitable trading activities

Unrestricted
funds
2025
£
Sales
753,414
Total 2024
613,434
Total
funds
2025
£
753,414
613,434
Total
funds
2024
£
613,434

The wholly owned trading subsidiary CCDC Services Limited is incorporated in the United Kingdom and pays all of its profits to the charity under a deed of covenant. The summary financial performance of the subsidiary is shown in note 15.

8. Investment income

Unrestricted
funds
2025
£
Investment income
191,975
Bank & other interest receivable
12,748
204,723
Total 2024
178,718
Total
funds
2025
£
191,975
12,748
204,723
178,718
Total
funds
2024
£
154,344
24,374
178,718

Page 50

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

9. Analysis of grants

Grants to
Institutions
2025
Total
funds
2025
£
£
Grants
164,262
164,262
Total 2024
376,551
376,551
The Group has made the following material grants to institutions during the year:
2025
£
Name of institution
Durham University
120,000
University of Strathclyde
-
University of Oxford
-
University of Liverpool
-
University of Leeds
22,000
University of São Paulo
11,149
153,149
Other grants to institutions
11,113
164,262
Total
funds
2024
£
376,551
2024
£
-
120,000
84,000
165,000
(11,827)
-
357,173
19,378
376,551

Page 51

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

10. Analysis of expenditure by activities

Scientific Activities
Total 2024
Activities
undertaken
directly
2025
£
7,733,152
8,461,513
Grant
funding of
activities
2025
£
164,262
376,551
Support
costs
2025
£
1,539,104
1,962,420
Total
funds
2025
£
9,436,518
10,800,484
Total
funds
2024
£
10,800,484

In 2025, restricted expenditure amounted to £1,128,771 (2024: £185,320) and unrestricted expenditure was £8,316,600 (2024: £10,625,126).

Analysis of direct costs

Wages and salaries
Attendance at scientific meetings
Legal and other professional fees
Consultants
Maintenance of scientific equipment
Production and distribution costs
Difference on foreign exchange
Staff development
Total 2024
Activities
2025
£
6,684,356
188,137
500
257,149
373,650
74,807
127,000
27,553
7,733,152
8,461,513
Total
funds
2025
£
6,684,356
188,137
500
257,149
373,650
74,807
127,000
27,553
7,733,152
8,461,513
Total
funds
2024
£
7,120,280
279,525
3,528
497,220
425,997
62,018
44,047
28,898
8,461,513

Page 52

(A Company Limited by Guarantee)

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

10. Analysis of expenditure by activities (continued)

Analysis of support costs

Activities
2025
£
Staff costs
688,741
Depreciation
114,426
Consultancy
-
Telephone and network costs
10,575
Recruitment
22,577
Legal and other professional fees
28,551
Audit and accountancy
99,475
Banking costs
44,814
Difference on foreign exchange
157,806
Insurance
41,284
Premises costs
183,637
Bad debt expense
(4,803)
IT equipment, software and hardware
58,711
General expenses
46,024
Staff development
20,805
Board meeting costs
26,481
1,539,104
Total 2024
1,962,420
11.
Auditor's remuneration
Fees payable to the Charity's auditor for the audit of the Charity's annual
accounts
Fees payable to the Charity's auditor in respect of:
All taxation advisory services not included above
All non-audit services not included above
Total
funds
2025
£
688,741
114,426
-
10,575
22,577
28,551
99,475
44,814
157,806
41,284
183,637
(4,803)
58,711
46,024
20,805
26,481
1,539,104
1,962,420
2025
£
36,900
1,550
4,700
Total
funds
2024
£
1,075,772
115,634
51,782
14,649
44,731
76,198
87,550
42,051
27,019
40,848
150,263
17,251
47,146
47,286
89,745
34,495
1,962,420
2024
£
32,000
1,330
5,350

Page 53

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

12. Staff costs

Wages and salaries
Social security costs
Other pension costs
Group
2025
£
5,992,154
653,482
727,461
7,373,097
Group
2024
£
6,663,402
723,492
809,158
8,196,052
Charity
2025
£
5,629,671
624,567
701,445
6,955,683
Charity
2024
£
6,002,614
628,717
758,867
7,390,198

In 2025, 2 redundancies and 1 termination occurred. This resulted in 3 employees receiving Payment in Lieu of Notice of £49,664.26 and 2 employees receiving termination payments of £22,526.

In 2024, a restructuring took place, resulting in 10 employees receiving Payment In Lieu Of Notice totaling £234,507. Of these 10 employees 6 also received severance payments totaling £119,782.

The average number of persons employed by the Charity during the year was as follows:

Office and administration
Technical
Group
2025
No.
10
86
96
Group
2024
No.
10
99
109
Charity
2025
No.
9
82
91
Charity
2024
No.
9
92
101

Page 54

(A Company Limited by Guarantee)

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

12. Staff costs (continued)

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:

Group Group
2025 2024
No. No.
In the band £60,001 - £70,000 16 14
In the band £70,001 - £80,000 6 8
In the band £80,001 - £90,000 8 7
In the band £90,001 - £100,000 5 8
In the band £100,001 - £110,000 2 -
In the band £110,001 - £120,000 1 2
In the band £120,001 - £130,000 2 1
In the band £150,001 - £160,000 - 1
In the band £310,001 - £320,000 - 1

The Key Management Personnel of the charity comprise the trustees, the Executive Director and the Senior Leadership Management Team. No trustees (2024 - one) received a leaving gift worth £NIL (2024 - £221), no other trustees received any remuneration or benefits in kind from the charity (2024 - £NIL). The total employee benefits of the Key Management Personnel, including employers' NIC and employers pension of the charity were £905,643 (2024 - £1,378,666).

A total of £9,405 (2024 - £19,301) was reimbursed or paid directly to 6 (2024 - 7) trustees in respect of travel and accommodation costs.

13. Taxation

Taxation
Current tax on net income/(expenditure) for the year
Taxation on net income/(expenditure)
2025
£
8,852
8,852
2024
£
9,962
9,962

Page 55

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

13. Taxation (continued)

The Charity is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the Charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.

In accordance with the deed of covenant, the CCDC Services's taxable profits for the year of £423,307 (2024 - £421,153) have been distributed in favour of The Cambridge Crystallographic Data Centre. Therefore there are Nil profits on which to be taxed. CCDC Services Limited, is a wholly owned subsidiary of The Cambridge Crystallographic Data Centre. CCDC Services Limited is registered in England and Wales, company number 03483374. The registered office is 12 Union Road, Cambridge, CB2 1EZ.

The taxation of £8,852 relates soley to the CCDC Inc, a wholly owned subsidiary of The Cambridge Crystallographic Data Centre. CCDC Inc is registrered within the United States of America and the registered office is One Boston Place, Suite 2600, Boston, MA 02108.

Page 56

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

14. Tangible fixed assets

Group

Cost or valuation
At 1 January 2025
Additions
Disposals
At 31 December 2025
Depreciation
At 1 January 2025
Charge for the year
On disposals
At 31 December 2025
Net book value
At 31 December 2025
At 31 December 2024
Long-term
leasehold
property
£
4,508,917
23,181
-
4,532,098
2,408,348
90,487
-
2,498,835
2,033,263
2,100,569
Fixtures,
fittings and
equipment
£
727,790
-
(54,720)
673,070
628,242
23,941
(54,720)
597,463
75,607
99,548
Total
£
5,236,707
23,181
(54,720)
5,205,168
3,036,590
114,428
(54,720)
3,096,298
2,108,870
2,200,117

Page 57

(A Company Limited by Guarantee)

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

14. Tangible fixed assets (continued)

Charity

Cost or valuation
At 1 January 2025
Additions
Disposals
At 31 December 2025
Depreciation
At 1 January 2025
Charge for the year
On disposals
At 31 December 2025
Net book value
At 31 December 2025
At 31 December 2024
Long-term
leasehold
property
£
4,508,917
23,181
-
4,532,098
2,408,348
90,487
-
2,498,835
2,033,263
2,100,569
Fixtures,
fittings and
equipment
£
727,790
-
(54,720)
673,070
628,242
23,941
(54,720)
597,463
75,607
99,548
Total
£
5,236,707
23,181
(54,720)
5,205,168
3,036,590
114,428
(54,720)
3,096,298
2,108,870
2,200,117

Page 58

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

15. Fixed asset investments

Group
Cost or valuation
At 1 January 2025
Additions
Revaluations
At 31 December 2025
Charity
Cost or valuation
At 1 January 2025
Additions
Revaluations
At 31 December 2025
Investments
in
subsidiary
companies
£
163,489
-
-
163,489
Listed
investments
£
7,524,291
173,975
900,598
8,598,864
Listed
investments
£
7,524,291
173,975
900,598
8,598,864
Total
£
7,687,780
173,975
900,598
8,762,353

All the listed fixed asset investments are held in the UK.

All investments are carried at their fair value. Investments in equities and fixed interest securities are all traded in quoted public markets, primarily the London Stock Exchange. Holdings in common investment funds, unit trusts and open-ended investment companies are at bid price. The basis of fair value for quoted investments is equivalent to the market value, using the bid price. Asset sales and purchases are recognised at the date of trade at cost (that is their transaction value).

The Charity does not make use of derivatives and similar complex financial instruments as it takes the view that investments are held for long term growth and annual income.

The Group has no material investment holdings in markets subject to exchange controls or trading restrictions.

Page 59

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

15. Fixed asset investments (continued)

Principal subsidiaries

The following were subsidiary undertakings of the Charity:

Names Company Registered office or principal Principal activity number place of business CCDC Services Limited 03483374 12 Union Road, Cambridge, CB2 Provision of 1EZ professional services for digital drug design and manufacture, and advanced training CCDC Inc One Boston Place, Suite 2600, To provide services to Boston, MA 02108, United States the parent company, such as Education and Outreach, training, customer service and sales." Class of Holding Included in shares consolidation Ordinary 100% Yes Capital 100% Yes

The financial results of the subsidiaries for the year were:

Names Income Expenditure Profit/(Loss) Net assets
£ £ for the year £
£
CCDC Services Limited 757,354 (334,047) 423,307 2,118
CCDC Inc 494,793 (515,432) (20,639) 365,034

Page 60

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

16. Debtors

Due within one year
Trade debtors
Amounts owed by group undertakings
Other debtors
Prepayments and accrued income
Group
2025
£
2,694,335
-
452,043
308,048
3,454,426
Group
2024
£
3,115,568
-
135,150
502,112
3,752,830
Charity
2025
£
2,504,371
714,393
425,167
304,554
3,948,485
Charity
As restated
2024
£
2,968,807
397,382
91,977
493,084
3,951,250

17. Creditors: Amounts falling due within one year

Trade creditors
Amounts owed to group undertakings
Other taxation and social security
Other creditors
Accruals and deferred income
Deferred income at 1 January 2025
Resources deferred during the year
Amounts released from previous periods
Group
2025
£
54,762
-
258,084
188,749
5,062,088
5,563,683
Group
2025
£
5,349,639
5,269,505
(5,349,639)
5,269,505
Group
2024
£
38,828
-
300,965
114,221
5,172,129
5,626,143
Group
2024
£
5,239,996
5,349,639
(5,239,996)
5,349,639
Charity
2025
£
51,707
229,662
257,453
188,749
5,035,010
5,762,581
Charity
2025
£
5,255,045
5,269,505
(5,255,045)
5,269,505
Charity
2024
£
38,460
61,664
279,756
114,221
5,058,285
5,552,386
Charity
2024
£
5,191,138
5,255,045
(5,191,138)
5,255,045

Deferred income relates to subscriptions received in advance of which £4,947,725 (2024: £5,079,751) relates to amounts due within 1 year and £321,780 (2024: £269,888) relates to amounts due after 1 year. Refer to note 18 for the details on amounts due after 1 year.

Page 61

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

18. Creditors: Amounts falling due after more than one year

Other creditors
Deferred income
Group
2025
£
414,188
321,780
735,968
Group
2024
£
405,375
269,888
675,263
Charity
2025
£
414,188
321,780
735,968
Charity
2024
£
405,375
269,888
675,263

19. Prior year adjustments

For the year ended 31 December 2024, the donation from the trading subsidiary CCDC Services Limited to its parent Cambridge Crystallographic Data Centre was recognised in the consolidated financial statements but was not recognised in the individual charity financial statements and the related disclosures.

This error has resulted in an understatement of opening debtors and reserves of £421,153 in the financial statements of The Cambridge Crystallographic Data Centre.

The error has been corrected by restating the comparative information. The impact of the correction is to increase debtors and reserves by £421,153 in the comparative period.

Page 62

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

20. Statement of funds Statement of funds - current year

Unrestricted
funds
Designated
funds
Fixed Asset
Fund
Research and
Development
Fund
Sponsorship and
Outreach Fund
CSD and
Sustainability
Fund
Balance at 1
January
2025
£
2,200,117
173,406
65,394
100,086
2,539,003
Income
£
-
-
-
-
-
Expenditure
£
(114,428)
-
(164,262)
-
(278,690)
Transfers
in/(out)
£
23,181
-
98,868
-
122,049
Gains/
(Losses)
£
-
-
-
-
-
Balance at
31
December
2025
£
2,108,870
173,406
-
100,086
2,382,362

Page 63

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

20. Statement of funds (continued)

General funds
General Funds
Total
Unrestricted
funds
Restricted
funds
BioChem
GRAPH
Google Ad grant
SHARPEN grant
DigiCCAMMS
Grant
PSDI Grant
DPN-MED Grant
CERSI Grant
Green Impact
Programme
Grant
Total of funds
Balance at 1
January
2025
£
6,282,127
8,821,130
(8,054)
-
-
-
-
-
-
-
(8,054)
8,813,076
Income
£
9,954,949
9,954,949
-
27,071
214,529
204,163
34,331
7,491
47,743
15,000
550,328
10,505,277
Expenditure
£
(8,188,567)
(8,467,257)
-
(27,071)
(505,438)
(341,039)
(34,331)
(7,491)
(47,743)
(15,000)
(978,113)
(9,445,370)
Transfers
in/(out)
£
(557,888)
(435,839)
8,054
-
290,909
136,876
-
-
-
-
435,839
-
Gains/
(Losses)
£
900,598
900,598
-
-
-
-
-
-
-
-
-
900,598
Balance at
31
December
2025
£
8,391,219
10,773,581
-
-
-
-
-
-
-
-
-
10,773,581

Page 64

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

20. Statement of funds (continued)

Statement of funds - prior year

Unrestricted
funds
Designated
funds
Fixed Asset
Fund
Research and
Development
Fund
Sponsorship and
Outreach Fund
CSD and
Sustainability
Fund
Pension
Provision Fund
General funds
General Funds
Total
Unrestricted
funds
Balance at
1 January
2024
£
2,294,451
173,406
40,945
100,086
908,000
3,516,888
5,733,643
9,250,531
Income
£
-
-
-
-
-
-
9,759,196
9,759,196
Expenditure
£
(115,633)
-
(376,551)
-
-
(492,184)
(10,132,942)
(10,625,126)
Transfers
in/out
£
21,299
-
401,000
-
(908,000)
(485,701)
436,398
(49,303)
Gains/
(Losses)
£
-
-
-
-
-
-
485,832
485,832
Balance at
31
December
2024
£
2,200,117
173,406
65,394
100,086
-
2,539,003
6,282,127
8,821,130

Page 65

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

20. Statement of funds (continued)

Restricted
funds
BioChem
GRAPH
ROYCE grant
Google Ad grant
Regulatory
Network Grant
SHARPEN grant
Total of funds
Balance at
1 January
2024
£
7,406
-
-
-
-
7,406
9,257,937
Income
£
-
7,132
70,125
13,630
29,670
120,557
9,879,753
Expenditure
£
(21,874)
(30,241)
(70,125)
(13,630)
(49,450)
(185,320)
(10,810,446)
Transfers
in/out
£
6,414
23,109
-
-
19,780
49,303
-
Gains/
(Losses)
£
-
-
-
-
-
-
485,832
Balance at
31
December
2024
£
(8,054)
-
-
-
-
(8,054)
8,813,076

Page 66

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

20. Statement of funds (continued)

The purpose of funds above are detailed as follows:

DESIGNATED FUNDS:

Fixed Asset Fund: This fund represents the balance of the groups' reserves held as fixed assets. The transfer represents movements to fixed assets in the year.

Research and Development Fund: This fund finances research activities and makes grants for research where general funds are not available for this purpose.

Sponsorship and Outreach Fund : This fund supports the cost of funding studentships worldwide.

CSD and Sustainability Fund: This fund is established to provide support in the event of unexpected legal, legislative or regulatory events which might have a negative effect on the Centre.

RESTRICTED FUNDS:

Google Ad: CCDC receives a Google Ads Grant, as part of Google's programme to support nonprofits (https://www.google.co.uk/grants/ ). This awards us a monthly sum (max $10,000) to spend on Google advertising, which we use to promote our Access Structures service, training and learning resources, teaching materials, and events — all of which are free resources for the community. We also promote our general about us video using the grant, to raise awareness of the CCDC and our charitable activities as a whole.

BioChemGRAPH: The BioChemGRAPH project aims to establish a collaboration between PDBe, ChEMBL and CCDC to create an easily accessible resource that integrates structural, functional and biochemical annotations of small molecule data into one place. This project will promote interoperability between small molecule resources by implementing common data standards. The project also aims to improve the findability and accessibility of small molecule annotations via uniform data access mechanisms and develop intuitive web components to visualise these valuable data through web interfaces. It will significantly increase the synergies between structural and biochemical data and will lead to increased understanding of the role of small molecules in biological systems and translational research in a number of areas, including synthetic biology, target validation, and drug development. The project started on 2 November 2020 and will last 36 months. The project was extended by 12 months to 2 November 2024 due to changes in partner institute. BioChemGRAPH was funded by BBSRC, 20% of the costs will be covered by the general fund.

ROYCE: This project was an effort to augment the crystal structure data within the CSD, with calculated physical property data, of relevance to Organic Semi-Conductor (OSC) design. Following the Q4 2024 data release, researchers will be able to place the results of their own proposed OSC's, within the context of all known OSCs in the CSD; alongside understanding molecular properties such as HOMO-LUMO Gap and singlet state energies, the major barrier to widespread adoption of OSC is the tuning of crystallographic dependent properties, such as transfer integral and dynamic disorder. This project has delivered a platform for assessing proposed OSCs rapidly. The grant was funded by Henry Royce Institute. It started on 1 October 2023 with a completion date of 29 February 2024.

Regulatory network: The Regulatory Network grant was the Discovery Phase of a two phase competition to create Centres for Excellence in Regulatory Science and Innovation (CERSIs) for the UK. This grant involved building a consortium to prepare a proposal for the Implementation Phase of this competition to create a CERSI for Digital Chemistry Manufacturing and Control (CMC). This second proposal was successfully funded.

Page 67

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

20. Statement of funds (continued)

Sharpen: The SHARPEN grant intends to enable data sharing across the medicines manufacturing industry through a federated learning approach. The grant involves evolving CCDC's structural data platform to improve usability and data linking, and extending our Particle Informatics models.

DigiCCAMMS: (Digital Crystallisation Control for Advanced Medicines Manufacturing Sustainability) is a 24-month Innovate UK funded Sustainable Medicines Manufacturing Collaborative R&D project between CCDC and Durham University. The project will embed a new method to predict crystal shape into CCDC's desktop software that can take crystallisation conditions, such as solvent and supersaturation, into account. Experimental crystallisation data generated at Durham University will be used to benchmark and validate the computational tools. DigiCCAMMS runs from 1st February 2025 to 31st January 2027.

The UK Physical Sciences Data Infrastructure (PSDI): is an initiative funded by EPSRC to enable better science and innovation by building the platforms, tools and skills needed to make physical sciences data more accessible and trustworthy. The CCDC is funded as a PSDI Partner organisation. The grant will end in March 2026.

DPN-MED: (Digital Plug-and-Produce Network for Sustainable Medicines Development and Manufacturing) was a 6-month Innovate UK funded Sustainable Medicines Manufacturing Grand Challenge Expression of Interest between CCDC, the University of Strathclyde (CMAC), and the National Manufacturing Institute for Scotland (NMIS). The project sought to develop a consortium to deliver a Grand Challenge focused on automated, "plug and produce" distributed architectures for sustainable medicines manufacturing. CCDC had proposed to develop its web-based tools for predicted crystal structure data and analysis as part of the Grand Challenge. Ultimately this Expression of Interest was not successful for subsequent Grand Challenge funding. DPN-MED ran from 1st January 2025 to 30th June 2025.

The CERSI: for the Digital Transformation of Medicines Development and Manufacturing (Digital CMC CERSI) was a 14-month MHRA funded collaboration between CCDC, the University of Strathclyde (CMAC), De Montford University, and a variety of unfunded industry partners. The project sought to define a framework to enable the regulatory readiness of digital tools for pharmaceutical chemistry, manufacturing, and controls (CMC) to be assessed and developed, alongside a variety of training resources and demonstrable case studies. CCDC provided its digital solid form healthcheck as a case study alongside relevant training material. Digital CMC CERSI ran from 1st February 2025 to 31st March 2026.

Green Business Impact Programme grant: The CCDC received a £15,000 one-off capital grant through the Green Business Impact Programme, administered by Allia Impact Ltd on behalf of a consortium including Cambridge City Council and the Cambridgeshire & Peterborough Combined Authority. The funding supported the installation of solar photovoltaic panels as part of the organisation’s transition towards net zero and improved energy sustainability.

Page 68

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

21. Analysis of net assets between funds

Analysis of net assets between funds - current year

Unrestricted
funds
2025
£
Tangible fixed assets
2,108,870
Fixed asset investments
8,598,864
Current assets
6,382,581
Creditors due within one year
(5,580,766)
Creditors due in more than one year
(735,968)
Total
10,773,581
Total
funds
2025
£
2,108,870
8,598,864
6,382,581
(5,580,766)
(735,968)
10,773,581

Analysis of net assets between funds - prior year

Tangible fixed assets
Fixed asset investments
Current assets
Creditors due within one year
Creditors due in more than one year
Total
Unrestricted
funds
2024
£
2,200,117
7,524,291
5,398,128
(5,626,143)
(675,263)
8,821,130
Restricted
funds
2024
£
-
-
(8,054)
-
-
(8,054)
Total
funds
2024
£
2,200,117
7,524,291
5,390,074
(5,626,143)
(675,263)
8,813,076

Page 69

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

22. Reconciliation of net movement in funds to net cash flow from operating activities

Net income/expenditure for the year (as per Statement of Financial
Activities)
Adjustments for:
Depreciation charges
14
Gain on investments
15
Dividends, interests and rents from investments
8
Decrease/(increase) in debtors
16
(Decrease)/increase in creditors
17,18
Movement in foreign exchange reserve
Net cash provided by/(used in) operating activities
23.
Analysis of cash and cash equivalents
Cash in hand
Total cash and cash equivalents
24.
Analysis of changes in net debt
At 1
January
2025
£
Cash at bank and in hand
1,637,244
1,637,244
Group
2025
£
1,960,505
114,428
(900,598)
(204,723)
298,404
(1,755)
-
1,266,261
Group
2025
£
2,911,072
2,911,072
Cash flows
£
1,273,828
1,273,828
Group
2024
£
(444,807)
115,634
(482,793)
(178,718)
(269,386)
270,462
(54)
(989,662)
Group
2024
£
1,637,244
1,637,244
At 31
December
2025
£
2,911,072
2,911,072

Page 70

(A Company Limited by Guarantee)

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

25. Pension commitments

The Group operates a defined benefit pension scheme.

The total pension cost for the Group for the period was £727,461 (2024 - £809,158).

Employer contributions for the year amounted to £531,034 for the Universities Superannuation Scheme and £44,415 for the Cambridge University Assistants Contributory Pension Scheme.

The Charity's employees belong to two principal pension schemes, the Universities Superannuation Scheme (USS) and the Cambridge University Assistants' Contributory Pension Scheme (CUACPS).

In 2022 the Charity added a third pension scheme, a defined contribution scheme. The assets of the scheme are held separately from those of the Group in an independently administered fund. The pension cost charge represents contributions payable by the Group to the fund.

CCDC Inc operates a defined contribution scheme. The assets of the scheme are held separately from those of the Group in an independently administered fund. The pension cost charge represents contributions payable by the Group to the fund and amounted to £26,016 (2024 - £50,291). No amounts were outstanding at the year end (2024 - £NIL).

Universities Superannuation Scheme

The charity participates in the Universities Superannuation Scheme, which is a multi-employer defined benefit pension scheme.

The scheme is a defined benefit plan in nature; however, it is not possible for the entity to identify its share of the underlying assets and liabilities of the scheme on a consistent and reasonable basis. Accordingly, in accordance with FRS 102, the scheme is accounted for as a defined contribution plan.

At the valuation date, the value of the assets of the scheme was £73.1 billion and the value of the scheme’s technical provisions was £65.7 billion indicating a surplus of £7.4 billion and a funding ratio of 111%.

The entity is therefore exposed to actuarial risks associated with the scheme, including changes in Where a deficit exists, a recovery plan has been agreed which requires participating employers to make additional contributions. The entity’s share of these deficit contributions is reflected in a provision recognised in the financial statements (where applicable).

The entity is therefore exposed to actuarial risks associated with the scheme, including changes in contribution rates arising from future valuations. These may impact the entity’s future cash flows.

No deficit recovery plan was required under the 2023 valuation because the scheme was in surplus on a technical provisions basis.

The latest available complete actuarial valuation of the the defined benefit part of the scheme, is as at 31 March 2023 (the valuation date), and was carried out using the projected unit method.

Page 71

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

25. Pension commitments (continued)

Price inflation - Consumer Prices Index (CPI) 3.0% pa (based on a long term average expected
level of CPI, broadly consistent with long term
market expectations)
RPI/CPI gap 1.0% pa to 2030, reducing to 0.1% pa from 2030
Price inflation - Retail Prices Index (RPI) In line with the CPI assumption plus the RPI/CPI
gap (i.e. 4.0% pa to 2030, reducing to 3.1% from
2030)
Discounts rate
Pre-retirement
Post-retirement
Fixed interest gilt yield curve plus:
2.5% pa
0.9% pa
Pension increases (all subject to a floor of 0%) Increases linked to CPI
Benefits with no cap: CPI assumption + 3bps
Benefits subject to a "soft cap" of 5% (providing
inflationary increases up to 5%, and half of any
excess inflation over 5% up to a maximum
increase of 10%): CPI assumption - 3bps
Increases capped at 2.5% (where applicable): CPI
assumption-96bps
Mortality base table 101% of S2PMA "light" for males and 95% of
S3PFA for females
Future improvements to mortality CMI_2021 with a smoothing parameter of 7.5, an
initial addition of 0.4% pa, 10% w2020 and w2021
parameters, and a long term improvement rate of
1.8% pa for males and 1.6% pa for females

Principal actuarial assumptions at the Balance Sheet date (expressed as weighted averages):

At 31 At 31
December December
2025 2024
Years Years
Mortality rates (in years)
- for a male aged 65 now 23.8 23.7
- at 65 for a male aged 45 now 25.7 25.6
- for a female aged 65 now 25.5 25.4
- at 65 for a female aged 45 now 27.2 27.2

Page 72

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

25. Pension commitments (continued)

Cambridge University Assistants' Contributory Pension Scheme

The charity participates in the Cambridge University Assistants Contributory Pension Scheme, which is a multi-employer defined benefit pension scheme.

The scheme is a defined benefit plan in nature; however, it is not possible for the entity to identify its share of the underlying assets and liabilities of the scheme on a consistent and reasonable basis. Accordingly, in accordance with FRS 102, the scheme is accounted for as a defined contribution plan. At the valuation date, the value of the assets of the scheme was £918 million and the value of the scheme’s liabilities was £880 million indicating a surplus of £38 million.

Where a deficit exists, a recovery plan has been agreed which requires participating employers to make additional contributions. The entity’s share of these deficit contributions is reflected in a provision recognised in the financial statements (where applicable).

The entity is therefore exposed to actuarial risks associated with the scheme, including changes in contribution rates arising from future valuations. These may impact the entity’s future cash flows.

No deficit recovery plan was required under the 2024 valuation because the scheme was in surplus

The latest available complete actuarial valuation of the the defined benefit part of the scheme, is as at 31 July 2024 (the valuation date), and was carried out using the projected unit method.

Price inflation - Consumer Prices Index (CPI) The Consumer Price Index (CPI) assumption will
be determined from the RPI increase assumption
less:
- 1.0% per annum to 2030;
-0.1% per annum from 2031 onwards
Price inflation - Retail Prices Index (RPI) This rate will then be adjusted by an allowance for
the Inflation Risk Premium, which for the purposes
of the 2024 valuation the Trustee has determined
should be:
- 0% per annum to 2023;
- 1.0% in 2031; and then
- Reducing by 0.1% per annum back to 0% per
annum in 2041 and thereafter
Discounts rate
Pre-retirement
Post-retirement
Fixed interest gilt yield curve plus:
2.8% pa
2.5% pa
Pension increases in payment The assumptions for future pension increases are
set equal to the assumptions for RPI and CPI
noted above, subject to these maxima
Pay increases Pay increases are expected to exceed CPI
increases by 1.5% per annum compound in the
long term but an allowance has been made for pay
increases of 5.7% in 2024/2025

Page 73

(A Company Limited by Guarantee)

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

24. Pension commitments (continued)

Mortality base table Male Members and Male Dependants - S4 All
Pensioners Amounts table ("S4PMA"), adjusted by
assuming members exhibit mortality rates at 106%
of the standard table;
- Female Memberrs - S4 All Pensioners Amounts
table ("S4PFA"), adjusted by assuming that
members exhibit mortality rates at 98% of the
standard table;
- Female Dependants - S4 Dependant Pensioners
Amounts table ("S4DFA"), adjusted by assuming
that members exhibit mortality rates at 118% of the
standard table.

26. Operating lease commitments

At 31 December 2025 the Group and the Charity had commitments to make future minimum lease payments under non-cancellable operating leases as follows:

Not later than 1 year
Later than 1 year and not later than 5 years
Group
2025
£
19,562
11,094
30,656
Group
2024
£
46,246
51,003
97,249
Charity
2025
£
19,562
11,094
30,656
Charity
2024
£
46,246
51,003
97,249

During the year the group had lease payments amounting to £30,433 (2024: £47,834) relating to the EV lease scheme offered to employees.

Page 74

(A Company Limited by Guarantee)

THE CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

27. Related party transactions

In 2025 the following transactions took place between the Charity and its wholly owned subsidiary CCDC Services Limited:

The provision of management services by the Charity to the company of £293,279 (2024: £190,224). The transfer under deed of covenant of the trading profits of CCDC Services Limited to the Charity of £423,307 (2024: £421,153).

At the year end a balance of £714,393 (2024: £397,382) was owed to the Charity by CCDC Services Limited.

In 2025 the following transactions took place between the Charity and its wholly owned subsidiary CCDC Inc:

The provision of a sales office and related services by the company to the Charity of £494,793 (2024: £947,781).

At the year end a balance of £229,660 (2024: £61,644) was due to CCDC Inc by the Charity.

There were no other outstanding balances with related parties as at 31 December 2025 (2024 - £NIL).

Other expenses incurred by the Charity on behalf of CCDC Services amounts to £NIL (2024 - £1,182).

Other expenses incurred by CCDC Inc on behalf of the Charity amounts to £NIL (2024 - £7,745).

Suzanna Ward (Executive Director) is a Trustee of British Crystallographic Association, of which the charity is a corporate member. The memebrship fee is £850, this was at an arm's length value.

28. Post balance sheet events

As part of its focus on long term sustainability and operational efficiency, during 2026 the Centre plans to transition the employment of its US based staff to an Employer of Record model, consistent with arrangements already used elsewhere outside the UK. CCDC Inc. will remain in place, but this administrative change is expected to reduce overhead and complexity and will not impact staff, users, partners or customers in the United States.

Page 75

DocuSeal

Audit Log

Envelope ID: 1070427

Verify

CCDC 31 December 2025 for signature.pdf

Original SHA256:

CCydnkhwILvTE9JX3b5PYpeUBa3Yn1WGn-KwVw-AJCc= Result SHA256:

F1ZrRhO4BL97sSgUMMDhIhvl2kR8oWv__xBuH2FJ8QM= Generated at: 28 May, 2026 13:52 BST

susan.bourne@uct.ac.za

Email verification: Verified IP: 128.232.192.73 Session ID: a54f8d669af6a5aa7af289ea36a671de User agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64; rv:151.0) Gecko/20100101 Firefox/151.0 Time zone: Africa/Johannesburg

SIGNATURE FIELD 1, SIGNATURE FIELD 2, SIGNATURE FIELD 3

Event Log

28 May, 2026 13:19 BST

Email sent to susan.bourne@uct.ac.za

28 May, 2026 13:52 BST 28 May, 2026 13:52 BST 28 May, 2026 13:52 BST 28 May, 2026 13:52 BST

Email link clicked by susan.bourne@uct.ac.za Form viewed by susan.bourne@uct.ac.za

Submission started by susan.bourne@uct.ac.za Submission completed by susan.bourne@uct.ac.za